<article id="rdi_calculator" class="slide" data-ag-slide-name="RDI Calculator">
    <div class="basic">
      <h1 data-ag-editable="RDI Calculator Main Title">Relative Dose Intensity (RDI)</h1>
      <div id="rdi_data_top">
         <p class="red_subtitle2" id="rdi_calculator_subheader" data-ag-editable="RDI Calculator Top Copy">Modelling and simulation of effect of dose reduction and cycle delay on tumor cell growth<sup>1-4</sup></p>
      </div>
      <div id="rdi_calc_data_holder">
         <p id="rdi_calc_data1" data-ag-editable="RDI Calculator Top Left Copy">Cell number</p>
         <p id="rdi_calc_data2" data-ag-editable="RDI Calculator Top Right Copy">Tumor</p>
         <p id="rdi_calc_data3" data-ag-editable="RDI Calculator Bottom Right Copy">Treatment cycles</p>
         <p id="rdi_calc_data4" data-ag-editable="RDI Calculator Bottom % Bar Copy">Dose reduction</p>
      </div>
      <div id="slide_e1" class="slide_e1">
         <div class="no_drag"></div>
         <canvas class="graph"></canvas>
         <div>
            <div class="sliderA"></div>
            <div class="sliderB"></div>
            <div class="sliderC"></div>
            <div class="sliderD"></div>
            <div class="sliderE"></div>
            <div class="sliderF"></div>
         </div>
         <div class="reduction">
            <div class="slider"></div>
            <div class="numbers"></div>
            <div class="slider_imitation"></div>
         </div>
         <div class="tumor"></div>
      </div>
    </div>
    <!-- Reference Information Starts -->
    <div class="lightbox_data" id="rdi_calculator_refs">
       <div class="main_content_style">
          <p><strong data-ag-editable="RDI Calculator References Title">References:</strong></p>
          <p class="refs_first" data-ag-editable="RDI Calculator References Sub Title">RDI modelling is based on publications in breast cancer and Non-Hodgkinâ€™s Lymphoma</p>
          <div data-ag-editable="RDI Calculator References List">
             <ol>
                <li>Chirivella L <em>et al.</em> Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients. Breast Cancer Res Treat 2009; 114(3):479-484</li>
                <li>Norton L <em>et al</em>. Evolving concepts in the systemic drug therapy of breast cancer. Semin Oncol. 1997 Aug;24(4 Suppl 10):S10-3-S10-10</li>
                <li>Bosly A <em>et al</em>. Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP. Ann Hematol. 2008; 87:277-283</li>
                <li>Pettengell R <em>et al</em>. Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy. Ann Hematol 2008; 87:429-430</li>
             </ol>
          </div>
       </div>
    </div>
    <!-- Reference Information Ends -->
</article>